The Lancet. Oncology.

ISSN 1470-2045Elsevier LtdUnited Kingdom
ScopusMEDLINEEmbasePubMedPMCSCImagoJIFMatched via identifier

Journal overview

Titles
The Lancet Oncology
Lancet Oncol. (abbreviated)
LANCET ONCOLOGY ELSEVIER SCIENCE INC
The Lancet. Oncology.
Lancet Oncol (abbreviated)
ISSN
1470-2045
1470-2045
eISSN
1474-5488
NLM ID
100957246
Publisher
Elsevier Ltd
London : Lancet Pub. Group, c2000-
Country
Language
English
ENG

Indexing & coverage

Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2000–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCNot found in this source

Metrics

MetricYearValueQuartileRankSource
JIF202535.9Q157JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
9.432
Best Quartile
Q1
H-index
455
Subject categories
  • Oncology — Q1
More metrics
Coverage
2000–2026
Country
United Kingdom
Region
Western Europe
Publisher
Elsevier Ltd
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
408
Total documents (3 years)
1333
Total references
7884
Total citations (3 years)
13495
Citable documents (3 years)
637
Citations per document (2 years)
9.41
References per document
19.32
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
1470-2045, 1474-5488
SCImago Source ID
12354
SCImago Rank (across all SCImago source types)
97

Publication activity

Publication activity
2025
408 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subject area (SCImago)
MeSH (PubMed)
Neoplasms
Scopus:2000-2026
MEDLINE:MEDLINE: v1n1, Sept. 2000-; Index medicusIn: PubMed: v1n1, Sept. 2000-;
PubMed:MEDLINE: v1n1, Sept. 2000-; Index medicusIn: PubMed: v1n1, Sept. 2000-;